Inhibitors of integrated stress response pathway
Abstract
The present disclosure relates generally to therapeutic agents that may be useful as inhibitors of Integrated Stress Response (ISR) pathway.
Más información
Fecha de publicación: | 2018 |
URL: | https://patents.google.com/patent/US20230047589A1/en?assignee=Praxis+biotech&oq=Praxis+biotech |
DOI: |
US20230047589A1 |